Wanling Lin

1.1k total citations · 1 hit paper
7 papers, 701 citations indexed

About

Wanling Lin is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wanling Lin has authored 7 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Pathology and Forensic Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wanling Lin's work include Lung Cancer Treatments and Mutations (2 papers), interferon and immune responses (1 paper) and Cancer Mechanisms and Therapy (1 paper). Wanling Lin is often cited by papers focused on Lung Cancer Treatments and Mutations (2 papers), interferon and immune responses (1 paper) and Cancer Mechanisms and Therapy (1 paper). Wanling Lin collaborates with scholars based in China and Taiwan. Wanling Lin's co-authors include Qian Chu, Yaling Long, Kongming Wu, Huan Zhang, Yunkai Yang, Shanshan Huang, Qian Chu, Yuan Chen, Yang Yang and Lei Wang and has published in prestigious journals such as Signal Transduction and Targeted Therapy, Oxidative Medicine and Cellular Longevity and Evidence-based Complementary and Alternative Medicine.

In The Last Decade

Wanling Lin

7 papers receiving 699 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Notch signaling pathway: architecture, disease, and therapeutics

2022 646 citations Wanling Lin, Yaling Long et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wanling Lin China	5	392	159	131	79	79	7	701
Yaling Long China	6	384 1.0×	170 1.1×	130 1.0×	89 1.1×	77 1.0×	8	683
Yunkai Yang China	5	403 1.0×	180 1.1×	132 1.0×	84 1.1×	82 1.0×	8	735
Kalliopi Tzavlaki Sweden	6	445 1.1×	139 0.9×	144 1.1×	69 0.9×	89 1.1×	7	742
Ning Yin China	13	452 1.2×	145 0.9×	181 1.4×	97 1.2×	54 0.7×	44	699
Ping Guo China	13	421 1.1×	179 1.1×	181 1.4×	46 0.6×	97 1.2×	23	695
Xiaoming Hou China	19	382 1.0×	175 1.1×	207 1.6×	126 1.6×	111 1.4×	60	747
Chris Siebel United States	4	533 1.4×	119 0.7×	128 1.0×	56 0.7×	97 1.2×	4	804
Maria Florescu Romania	16	570 1.5×	143 0.9×	160 1.2×	79 1.0×	65 0.8×	34	1.1k
Chenghua Luo China	15	283 0.7×	118 0.7×	84 0.6×	96 1.2×	73 0.9×	59	749
Claudia A. Benavente United States	15	376 1.0×	209 1.3×	97 0.7×	45 0.6×	78 1.0×	24	709

Countries citing papers authored by Wanling Lin

Since Specialization

Citations

This map shows the geographic impact of Wanling Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanling Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanling Lin more than expected).

Fields of papers citing papers by Wanling Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanling Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanling Lin. The network helps show where Wanling Lin may publish in the future.

Co-authorship network of co-authors of Wanling Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Wanling Lin. A scholar is included among the top collaborators of Wanling Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanling Lin. Wanling Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Huang, Shanshan, Yaling Long, Yuan Gao, et al.. (2024). Combined inhibition of MET and VEGF enhances therapeutic efficacy of EGFR TKIs in EGFR-mutant non-small cell lung cancer with concomitant aberrant MET activation. Experimental Hematology and Oncology. 13(1). 97–97. 8 indexed citations

2.

Wang, Ren‐Ching, et al.. (2022). Investigating early progression of Hodgkin lymphoma in a two-center analysis. Journal of the Formosan Medical Association. 121(7). 1215–1222. 1 indexed citations

3.

Huang, Shanshan, Wanling Lin, Lei Wang, et al.. (2022). SIX1 Predicts Poor Prognosis and Facilitates the Progression of Non-small Lung Cancer via Activating the Notch Signaling Pathway. Journal of Cancer. 13(2). 527–540. 14 indexed citations

4.

Lin, Wanling, et al.. (2022). Nodular fasciitis of the breast: the report of three cases. BMC Women s Health. 22(1). 54–54. 4 indexed citations

5.

Lin, Wanling, Yaling Long, Yunkai Yang, et al.. (2022). Notch signaling pathway: architecture, disease, and therapeutics. Signal Transduction and Targeted Therapy. 7(1). 95–95. 646 indexed citations breakdown →

6.

Huang, Shanshan, Yongbiao Huang, Wanling Lin, et al.. (2022). Sitagliptin Alleviates Radiation‐Induced Intestinal Injury by Activating NRF2‐Antioxidant Axis, Mitigating NLRP3 Inf‐‐lammasome Activation, and Reversing Gut Microbiota Disorder. Oxidative Medicine and Cellular Longevity. 2022(1). 2586305–2586305. 23 indexed citations

7.

Xiao, Ling‐Yong, Yu Du, Huiyan Shi, et al.. (2021). Acupuncture for Hypertension in Animal Models: A Systematic Review and Meta-Analysis. Evidence-based Complementary and Alternative Medicine. 2021. 1–20. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact